Valuation: Tiansheng Pharmaceutical Group Co., Ltd.

Market Cap 1.61B 238M 206M 192M 177M 334M 22.66B 338M 2.26B 888M 11.34B 895M 875M 37.56B P/E 2024
-16.5x
P/E 2025 -27.9x
Enterprise Value 1.69B 250M 217M 202M 186M 351M 23.77B 354M 2.37B 931M 11.9B 939M 918M 39.4B EV / Sales 2024
2.7x
EV / Sales 2025 3.16x
Free-Float
52.84%
Yield 2024 *
-
Yield 2025 -
05-08 Tiansheng Pharmaceutical Secures Proposed Selection for Three Medicines in China's National Procurement MT
04-28 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-28 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02-12 Three Tiansheng Pharma Drugs Set to Win Bids for China's Drug Procurement Program MT
11-07 Tiansheng pharmaceutical and its controlling shareholder penalised, fined RE
29/10/25 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
14/10/25 Tiansheng Pharmaceutical Group Subsidiaries Tentatively Win Bulk Drug Tenders in Guangdong MT
15/09/25 Tiansheng Pharmaceutical Gets China Supplementary Drug Approval for Sodium Bicarbonate Injection MT
27/08/25 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
28/04/25 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
28/04/25 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
10/02/25 Tiansheng Pharmaceutical Passes Consistency Evaluation for Antibiotic MT
26/12/24 Chongqing Pharmaceutical Group Changsheng Pharmaceutical Co., Ltd announced that it expects to receive CNY 60 million in funding from C.Q. Pharmaceutical Holding Co., Ltd., Tiansheng Pharmaceutical Group Co., Ltd. CI
1 day+0.20%
1 week+2.64%
Current month+2.22%
1 month+0.60%
3 months-6.64%
6 months+2.02%
Current year+4.12%
1 week 4.88
Extreme 4.88
5.13
1 month 4.5
Extreme 4.5
5.13
Current year 4.32
Extreme 4.32
5.65
1 year 4.32
Extreme 4.32
5.81
3 years 3.17
Extreme 3.17
5.97
5 years 3.17
Extreme 3.17
5.99
10 years 3.17
Extreme 3.17
35.18
Manager TitleAgeSince
Chief Executive Officer 33 06/12/2018
Director of Finance/CFO 52 23/12/2013
Corporate Officer/Principal 54 11/12/2020
Director TitleAgeSince
Chairman 33 06/12/2018
Director/Board Member 54 11/12/2020
Director/Board Member 66 11/12/2020
Date Insider Type Main position Quantity % Market Cap.
25/07/23 Sell

Chief Financial Officer

43,100 0.0205%
Change 5-day change 1-year change 3-year change Capi.($)
+0.20%+2.64%+5.86%-3.44% 238M
+4.86%-3.32%+52.73%+160.26% 995B
+1.04%-2.99%+50.87%+52.38% 614B
+0.98%-6.49%+24.00%+66.66% 431B
+1.96%+0.83%+42.80%+37.60% 353B
-0.11%-4.07%+30.37%+39.73% 293B
+2.52%-8.36%+7.27%+10.32% 245B
+4.57%+5.21%+35.91%+67.64% 210B
-4.32%-12.94%-3.79%-44.56% 210B
-2.58%-0.73%+17.16%+67.46% 168B
Average +0.49%-3.01%+26.32%+45.41% 351.85B
Weighted average by Cap. +0.74%-3.95%+36.79%+75.03%

Financials

2024 2025
Net sales 570M 84.39M 73.09M 68.13M 62.66M 118M 8.02B 120M 801M 314M 4.01B 317M 310M 13.3B 514M 76.15M 65.95M 61.48M 56.54M 107M 7.24B 108M 722M 284M 3.62B 286M 280M 12B
Net income -87.4M -12.95M -11.21M -10.45M -9.61M -18.15M -1.23B -18.35M -123M -48.21M -616M -48.62M -47.55M -2.04B -55.42M -8.21M -7.11M -6.63M -6.1M -11.51M -781M -11.64M -77.89M -30.57M -391M -30.83M -30.15M -1.29B
Net Debt 97.19M 14.4M 12.47M 11.62M 10.69M 20.18M 1.37B 20.41M 137M 53.61M 685M 54.07M 52.88M 2.27B 78.93M 11.69M 10.13M 9.44M 8.68M 16.39M 1.11B 16.57M 111M 43.53M 556M 43.91M 42.94M 1.84B
Logo Tiansheng Pharmaceutical Group Co., Ltd.
Tiansheng Pharmaceutical Group Co Ltd is a China-based company primarily engaged in drug R&D, production, sales, and the cultivation and processing of traditional Chinese medicinal materials. The Company's products include tablets, capsules, granules, teas, pills, and injections. Product varieties cover pediatrics, gynecology, cardiovascular system, digestive system, orthopedics, respiratory medicine, and anti-infective treatment areas. The Company's products are mainly sold to the domestic market.
Employees
1,273
Date Price Change Volume
05/08/26 CN¥5.060 +0.20% 2,047,400
04/08/26 CN¥5.050 0.00% 2,688,100
03/08/26 CN¥5.050 +2.02% 1,594,750
31/07/26 CN¥4.950 +1.23% 1,487,950
30/07/26 CN¥4.890 -0.81% 1,216,800
  1. Stock Market
  2. Stocks
  3. 002872 Stock